Endurant Capital Management as of March 31, 2017
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 88 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | 4.4 | $14M | 310k | 44.41 | |
| Becton, Dickinson and (BDX) | 4.1 | $13M | 70k | 183.44 | |
| Universal Health Services (UHS) | 3.8 | $12M | 95k | 124.45 | |
| Shire | 3.7 | $12M | 66k | 174.23 | |
| DaVita (DVA) | 3.5 | $11M | 159k | 67.97 | |
| Aetna | 3.2 | $9.9M | 78k | 127.55 | |
| UnitedHealth (UNH) | 3.2 | $9.9M | 60k | 164.02 | |
| Anthem (ELV) | 3.0 | $9.3M | 56k | 165.37 | |
| Jazz Pharmaceuticals (JAZZ) | 2.9 | $8.9M | 61k | 145.12 | |
| Oxford Immunotec Global | 2.8 | $8.8M | 571k | 15.49 | |
| Catalent (CTLT) | 2.6 | $8.2M | 291k | 28.32 | |
| Express Scripts Holding | 2.5 | $7.8M | 118k | 65.91 | |
| Cardinal Health (CAH) | 2.5 | $7.6M | 93k | 81.55 | |
| Pfizer (PFE) | 2.4 | $7.5M | 221k | 34.21 | |
| Vwr Corp cash securities | 2.3 | $7.2M | 257k | 28.20 | |
| Celgene Corporation | 2.3 | $7.2M | 58k | 124.43 | |
| Allergan | 2.1 | $6.5M | 27k | 238.91 | |
| Walgreen Boots Alliance (WBA) | 2.0 | $6.3M | 76k | 83.06 | |
| AmerisourceBergen (COR) | 2.0 | $6.2M | 70k | 88.50 | |
| Thermo Fisher Scientific (TMO) | 1.9 | $5.9M | 39k | 153.60 | |
| Boston Scientific Corporation (BSX) | 1.8 | $5.6M | 226k | 24.87 | |
| GlaxoSmithKline | 1.8 | $5.6M | 132k | 42.16 | |
| Stryker Corporation (SYK) | 1.7 | $5.4M | 41k | 131.65 | |
| Hill-Rom Holdings | 1.7 | $5.2M | 74k | 70.61 | |
| Hologic (HOLX) | 1.6 | $5.1M | 120k | 42.55 | |
| Healthsouth | 1.5 | $4.7M | 110k | 42.81 | |
| Wright Medical Group Nv | 1.5 | $4.6M | 149k | 31.12 | |
| CVS Caremark Corporation (CVS) | 1.5 | $4.6M | 58k | 78.50 | |
| C.R. Bard | 1.4 | $4.2M | 17k | 248.55 | |
| Zoetis Inc Cl A (ZTS) | 1.3 | $4.0M | 76k | 53.37 | |
| Envision Healthcare | 1.3 | $4.0M | 66k | 61.32 | |
| Akorn | 1.2 | $3.8M | 158k | 24.08 | |
| Mylan Nv | 1.1 | $3.6M | 91k | 38.99 | |
| Mallinckrodt Pub | 1.0 | $3.1M | 70k | 44.58 | |
| Biogen Idec (BIIB) | 1.0 | $3.1M | 11k | 273.42 | |
| Centene Corporation (CNC) | 1.0 | $3.0M | 43k | 71.25 | |
| Laboratory Corp. of America Holdings (LH) | 0.9 | $2.9M | 20k | 143.46 | |
| Endologix | 0.8 | $2.4M | 335k | 7.24 | |
| K2m Group Holdings | 0.8 | $2.4M | 118k | 20.51 | |
| Halozyme Therapeutics (HALO) | 0.7 | $2.3M | 176k | 12.96 | |
| Mkt Vectors Biotech Etf etf (BBH) | 0.7 | $2.2M | 19k | 119.02 | |
| Charles River Laboratories (CRL) | 0.7 | $2.1M | 24k | 89.96 | |
| Fluidigm Corporation convertible cor | 0.7 | $2.1M | 3.2M | 0.68 | |
| Clovis Oncology | 0.7 | $2.0M | 32k | 63.67 | |
| Edwards Lifesciences (EW) | 0.6 | $2.0M | 21k | 94.06 | |
| Medtronic (MDT) | 0.6 | $2.0M | 25k | 80.56 | |
| Illumina (ILMN) | 0.6 | $1.8M | 11k | 170.65 | |
| Incyte Corporation (INCY) | 0.6 | $1.8M | 13k | 133.64 | |
| McKesson Corporation (MCK) | 0.6 | $1.8M | 12k | 148.24 | |
| Nanostring Technologies (NSTGQ) | 0.6 | $1.8M | 88k | 19.88 | |
| Teva Pharmaceutical Industries (TEVA) | 0.5 | $1.7M | 53k | 32.09 | |
| Nevro (NVRO) | 0.5 | $1.7M | 18k | 93.67 | |
| Amicus Therapeutics (FOLD) | 0.5 | $1.6M | 223k | 7.13 | |
| Aerie Pharmaceuticals | 0.5 | $1.5M | 33k | 45.36 | |
| Eli Lilly & Co. (LLY) | 0.5 | $1.5M | 18k | 84.12 | |
| Gilead Sciences (GILD) | 0.5 | $1.5M | 22k | 67.91 | |
| Newlink Genetics Corporation | 0.5 | $1.4M | 59k | 24.11 | |
| Varex Imaging (VREX) | 0.5 | $1.4M | 43k | 33.60 | |
| Diplomat Pharmacy | 0.4 | $1.4M | 85k | 15.94 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $1.4M | 341k | 4.00 | |
| Johnson & Johnson (JNJ) | 0.4 | $1.3M | 10k | 124.55 | |
| CONMED Corporation (CNMD) | 0.4 | $1.2M | 27k | 44.43 | |
| Zosano Pharma | 0.4 | $1.1M | 597k | 1.90 | |
| Puma Biotechnology (PBYI) | 0.3 | $1.1M | 30k | 37.20 | |
| Dermira | 0.3 | $1.1M | 31k | 34.12 | |
| Patterson Companies (PDCO) | 0.3 | $1.0M | 22k | 45.22 | |
| Dynavax Technologies (DVAX) | 0.3 | $1.0M | 174k | 5.95 | |
| Tivity Health | 0.3 | $928k | 32k | 29.09 | |
| Keryx Biopharmaceuticals | 0.3 | $875k | 142k | 6.16 | |
| Prothena (PRTA) | 0.3 | $815k | 15k | 55.82 | |
| Alder Biopharmaceuticals | 0.2 | $763k | 37k | 20.79 | |
| American Renal Associates Ho | 0.2 | $776k | 46k | 16.88 | |
| Humana (HUM) | 0.2 | $742k | 3.6k | 206.11 | |
| Zimmer Holdings (ZBH) | 0.2 | $716k | 5.9k | 122.10 | |
| PerkinElmer (RVTY) | 0.2 | $673k | 12k | 58.05 | |
| Inc Resh Hldgs Inc cl a | 0.2 | $514k | 11k | 45.89 | |
| Regeneron Pharmaceuticals (REGN) | 0.2 | $504k | 1.3k | 387.69 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $479k | 25k | 19.31 | |
| BioMarin Pharmaceutical (BMRN) | 0.1 | $448k | 5.1k | 87.84 | |
| CIGNA Corporation | 0.1 | $439k | 3.0k | 146.33 | |
| Hca Holdings (HCA) | 0.1 | $379k | 4.3k | 88.93 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $282k | 14k | 20.74 | |
| SPDR S&P Biotech (XBI) | 0.1 | $243k | 3.5k | 69.43 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $258k | 9.3k | 27.74 | |
| Exelixis (EXEL) | 0.1 | $214k | 9.9k | 21.68 | |
| Valeant Pharmaceuticals Int | 0.1 | $221k | 20k | 11.05 | |
| Spark Therapeutics | 0.1 | $213k | 4.0k | 53.25 | |
| Ocera Therapeutics | 0.1 | $200k | 153k | 1.31 |
